ERBB2 and neoplasm: A meaningful and reliable analysis of the relationship between tumor stage and HER2 positivity prevalence could not be carried out as most of them included a mixture of several stages in varied, often unknown proportions, not always providing the mapping of HER2 status to the tumor stage of the participants.